Varian readies On-Board Imager

Article

The FDA has signed off on a key imaging accessory for Varian's linear accelerators. The x-ray imaging subsystem, called On-Board Imager, will serve as an integrated, robotic platform for image-guided cancer treatment, improving the precision of cancer

The FDA has signed off on a key imaging accessory for Varian's linear accelerators. The x-ray imaging subsystem, called On-Board Imager, will serve as an integrated, robotic platform for image-guided cancer treatment, improving the precision of cancer treatments by targeting and tracking tumors in real-time. A critical piece of the company's image-guided radiation therapy (IGRT) initiative, the automated subsystem will help physicians adjust the focus of radiation to fit changing tumor locations due to changes in patient positioning and motion caused by physiological processes such as respiration.

On-Board Imager will be mounted on the linear accelerator via robotically controlled arms that operate along three axes of motion, allowing them to be positioned optimally for the best view of the tumor. An amorphous silicon flat-panel detector records digital images showing internal anatomic landmarks, tracking motion of the tumor. The subsystem incorporates a 150-kV x-ray tube that assists in generating CT-quality images from a moving gantry.

On-Board Imager will be sold as an option on Varian's newly installed high-energy Clinac linear accelerators and as an upgrade for most digital Clinac accelerators already in place at clinical sites. It will be standard on Trilogy, a linear accelerator developed to support stereotactic and other advanced forms of radiotherapy. Trilogy was introduced as a prototype in October 2003 and received FDA 510(k) clearance in January. In concert with On-Board Imager, Trilogy will utilize radiographic, fluoroscopic, and, later this year, 3D cone-beam CT images.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.